首页|炎琥宁联合孟鲁司特钠对急性支气管炎患儿临床症状、炎性指标及免疫功能的影响

炎琥宁联合孟鲁司特钠对急性支气管炎患儿临床症状、炎性指标及免疫功能的影响

扫码查看
目的 探讨炎琥宁联合孟鲁司特钠对急性支气管炎患儿临床症状、炎性指标及免疫功能的影响.方法 选取2019 年1 月—2023 年12 月济南市长清区人民医院收治的 84 例急性支气管炎患儿为研究对象,按随机数字表法将其分为对照组和观察组,各42例.对照组采取孟鲁司特钠治疗,观察组在对照组基础上联合炎琥宁治疗,两组均治疗1周.对比两组的临床症状消失时间、炎性指标、免疫功能及不良反应发生情况.结果 观察组肺部湿啰音消失时间、咳嗽消失时间及咳痰消失时间均短于对照组,组间差异有统计学意义(P<0.05).治疗后,两组白细胞介素-6、白细胞介素-8、白细胞介素-1β、肿瘤坏死因子-α、CD8+均低于治疗前,且观察组均低于对照组,差异有统计学意义(P<0.05);两组CD4+、CD3+及CD4+/CD8+均高于治疗前,且观察组均高于对照组,差异有统计学意义(P<0.05).两组不良反应发生率比较,差异无统计学意义(P>0.05).结论 炎琥宁联合孟鲁司特钠共同应用于急性支气管炎患儿治疗,可有效改善患儿临床症状及炎性指标,增强其免疫功能,且不良反应率较低,安全性良好.
Effects of Yanhuning Combined with Montelukast Sodium on Clinical Symptoms,Inflammatory Indicators and Immune Function of Children with Acute Bronchitis
Objective To investigate the effects of Yanhuning combined with montelukast sodium on clinical symptoms,inflammatory indicators and immune function of children with acute bronchitis.Methods A total of 84 children with acute bronchitis admitted to Changqing District People's Hospital of Jinan City from January 2019 to December 2023 were selected as the research objects,and were divided into a control group and an observation group according to random number table method,with 42 cases in each group.The control group received treatment with montelukast sodium,and the observation group received combined treatment with Yanhuning on the basis of the control group,both groups were treated for 1 week.The time of clinical symptom disappearance,inflammatory indicators,immune function and occurrence of adverse reactions were compared between the two groups.Results The disappearance time of lung moist rales,cough and expectoration in the observation group were shorter than those in the control group,and the difference was statistically significant(P<0.05).After treatment,interleukin-6,interleukin-8,interleukin-1β,tumor necrosis factor-α and CD8+in two groups were lower than before treatment,and the observation group were lower than control group,the difference was statistically significant(P<0.05);CD4+,CD3+and CD4+/CD8+in both groups were higher than before treatment,and the observation group were higher than control group,the difference was statistically significant(P<0.05).There was no significant difference in the incidence of adverse reactions between the two groups(P>0.05).Conclusion Yanhuning combined with Montelukast sodium in the treatment of acute bronchitis children,can effectively improve the clinical symptoms and inflammatory indicators,enhance the immune function of children,and the adverse reaction rate is low,good safety.

Acute bronchitisYanhuningMontelukast sodiumClinical symptomsInflammatory indicatorsImmune function

张殿府、刘得平、孙成超

展开 >

济南市长清区人民医院儿科,山东济南 250300

济南市第三人民医院儿科,山东济南 250300

急性支气管炎 炎琥宁 孟鲁司特钠 临床症状 炎性指标 免疫功能

2024

反射疗法与康复医学

反射疗法与康复医学

ISSN:
年,卷(期):2024.5(11)